中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2015年
1期
7-12
,共6页
关鸿志%柳青%陈琳%钱敏%刘智%管宇宙%任海涛%赵燕环%陈未
關鴻誌%柳青%陳琳%錢敏%劉智%管宇宙%任海濤%趙燕環%陳未
관홍지%류청%진림%전민%류지%관우주%임해도%조연배%진미
淀粉样神经病,家族性%前白蛋白%突变%活组织检查
澱粉樣神經病,傢族性%前白蛋白%突變%活組織檢查
정분양신경병,가족성%전백단백%돌변%활조직검사
Amyloid neuropathies,familial%Prealbumin%Mutation%Biopsy
目的 探讨转甲蛋白相关家族性淀粉样周围神经病(TTR-FAP)患者的临床、电生理、组织病理和遗传学表现.方法 对北京协和医院2006-2014年确诊的13个家系(先证者)和散发TTR-FAP病例进行临床观察、分期、系统评估和随访.对其中12例进行了周围神经和(或)肌肉活组织检查(活检),主要采用腓浅神经与腓骨短肌联合活检.同时采用转甲蛋白免疫组织化学染色和转甲蛋白基因检测.结果 (1)临床表现:13例先证者和散发病例,男性11例,女性2例,发病年龄17 ~53岁,平均37.7岁.5例以周围神经病起病;4例以晕厥和(或)短暂脑缺血发作样症状起病;4例以腹泻起病.从发病到确诊的平均时间为2.96年.全部患者均有感觉和运动性周围神经病和自主神经功能障碍.临床分期1期4例,2期5例,3期4例.(2)神经肌肉活检病理:周围神经病理改变为慢性活动性轴索性损害,肌肉病理改变以神经源性损害为主,刚果红和转甲蛋白免疫组织化学染色阳性,提示转甲蛋白阳性物质淀粉样物质在神经与肌肉中沉积.(3)基因检测发现10种点突变,其中E54Q点突变未见报道.(4)诊疗与转归:对全部患者予维生素营养神经治疗,3例近期予二氟尼柳治疗,5例于发病后3~6年死亡.结论 TTR-FAP呈现基因型和临床表型的多样性,经典的V30M型在我国可能不是优势类型.本组病例以早发型为主,部分患者进展迅速,可能与特定的基因突变类型有关.神经肌肉联合活检加转甲蛋白免疫组织化学染色可提供TTR-FAP组织学确诊证据.
目的 探討轉甲蛋白相關傢族性澱粉樣週圍神經病(TTR-FAP)患者的臨床、電生理、組織病理和遺傳學錶現.方法 對北京協和醫院2006-2014年確診的13箇傢繫(先證者)和散髮TTR-FAP病例進行臨床觀察、分期、繫統評估和隨訪.對其中12例進行瞭週圍神經和(或)肌肉活組織檢查(活檢),主要採用腓淺神經與腓骨短肌聯閤活檢.同時採用轉甲蛋白免疫組織化學染色和轉甲蛋白基因檢測.結果 (1)臨床錶現:13例先證者和散髮病例,男性11例,女性2例,髮病年齡17 ~53歲,平均37.7歲.5例以週圍神經病起病;4例以暈厥和(或)短暫腦缺血髮作樣癥狀起病;4例以腹瀉起病.從髮病到確診的平均時間為2.96年.全部患者均有感覺和運動性週圍神經病和自主神經功能障礙.臨床分期1期4例,2期5例,3期4例.(2)神經肌肉活檢病理:週圍神經病理改變為慢性活動性軸索性損害,肌肉病理改變以神經源性損害為主,剛果紅和轉甲蛋白免疫組織化學染色暘性,提示轉甲蛋白暘性物質澱粉樣物質在神經與肌肉中沉積.(3)基因檢測髮現10種點突變,其中E54Q點突變未見報道.(4)診療與轉歸:對全部患者予維生素營養神經治療,3例近期予二氟尼柳治療,5例于髮病後3~6年死亡.結論 TTR-FAP呈現基因型和臨床錶型的多樣性,經典的V30M型在我國可能不是優勢類型.本組病例以早髮型為主,部分患者進展迅速,可能與特定的基因突變類型有關.神經肌肉聯閤活檢加轉甲蛋白免疫組織化學染色可提供TTR-FAP組織學確診證據.
목적 탐토전갑단백상관가족성정분양주위신경병(TTR-FAP)환자적림상、전생리、조직병리화유전학표현.방법 대북경협화의원2006-2014년학진적13개가계(선증자)화산발TTR-FAP병례진행림상관찰、분기、계통평고화수방.대기중12례진행료주위신경화(혹)기육활조직검사(활검),주요채용비천신경여비골단기연합활검.동시채용전갑단백면역조직화학염색화전갑단백기인검측.결과 (1)림상표현:13례선증자화산발병례,남성11례,녀성2례,발병년령17 ~53세,평균37.7세.5례이주위신경병기병;4례이훈궐화(혹)단잠뇌결혈발작양증상기병;4례이복사기병.종발병도학진적평균시간위2.96년.전부환자균유감각화운동성주위신경병화자주신경공능장애.림상분기1기4례,2기5례,3기4례.(2)신경기육활검병리:주위신경병리개변위만성활동성축색성손해,기육병리개변이신경원성손해위주,강과홍화전갑단백면역조직화학염색양성,제시전갑단백양성물질정분양물질재신경여기육중침적.(3)기인검측발현10충점돌변,기중E54Q점돌변미견보도.(4)진료여전귀:대전부환자여유생소영양신경치료,3례근기여이불니류치료,5례우발병후3~6년사망.결론 TTR-FAP정현기인형화림상표형적다양성,경전적V30M형재아국가능불시우세류형.본조병례이조발형위주,부분환자진전신속,가능여특정적기인돌변류형유관.신경기육연합활검가전갑단백면역조직화학염색가제공TTR-FAP조직학학진증거.
Objective To investigate the clinical,electrophysiological,histopathological and genetic findings in patients with transthyretin (TTR)-associated familial amyloid polyneuropathy (FAP) (TTR-FAP) in China.Methods Familial or sporadic cases of TTR-FAP of Chinese Han orgin diagnosed at Peking Union Medical College Hospital in the past eight years (2006-2014) were retrospectively reviewed.Clinical,neuropathological and genetic characteristics of these patients were evaluated.Results Thirteen cases with TTR-FAP diagnosed by pathology and genetic screening were collected.Clinically,all patients exhibited distal symmetric motor and sensory neuropathy with sensory loss of the lower and upper limbs.Five patients experienced muscle pain,2 had transient ischemic attack and all had various autonomic involvements.Other affected organs include cardiomyopathy in 12 cases,thyroid infiltration in 3 cases and leptomeningeal enhancement in 4.Nerve conduction studies showed sensorimotor axonal neuropathy in all patients.Histologically,5 of 10 patients were found amyloid deposit in peripheral nerve.All the cases were positive for muscular amyloid and TTR immuonstaining.TTR-positive amyloid deposits were detected in 5 of 11 patients who performed peripheral nerve biopsy and in all the 10 cases that performed muscle TTR staining.Genetically,of the 13 TTR-FAP patients,9 reported and one novel TTR mutations (E54Q) were identified in the TTR gene.Conclusions TTR-FAP may be under-diagnosed in Chinese population and should be considered in patients with chronic progressive neuropathy accompanied by multisystem involvements.Combined biopsy of peroneus brevis muscle and superficial peroneal nerve might be a prime choice to get positive pathological findings.Genetic screening is mandatory but no specific genotypephenotype correlations should be expected.G47R may be the most common mutation in Chinese FAP cases.